Published ahead of print on November 14, 2003, doi:10.1165/rcmb.2003-0066OC
American Journal of Respiratory Cell and Molecular Biology. Vol. 30, pp. 651-661, 2004
© 2004 American Thoracic Society DOI: 10.1165/rcmb.2003-0066OC
Immunostimulatory DNA Inhibits Transforming Growth Factor-ß Expression and Airway Remodeling
Jae Youn Cho,
Marina Miller,
Kwang Je Baek,
Ji Won Han,
Jyothi Nayar,
Monica Rodriguez,
Sook Young Lee,
Kirsti McElwain,
Shauna McElwain,
Eyal Raz and
David H. Broide
Department of Medicine, University of California San Diego School of Medicine, La Jolla, California
Address correspondence to: David H. Broide, M.B., Ch.B., University of California San Diego, Basic Science Building, Room 5090, 9500 Gilman Drive, La Jolla, CA 92093-0635. E-mail: dbroide{at}ucsd.edu
Immunostimulatory sequences of DNA (ISS) inhibit eosinophilic airway inflammation, Th2 responses, and airway hyperreactivity (AHR) in mouse models of acute ovalbumin (OVA)-induced airway inflammation. To determine whether ISS inhibits airway remodeling, we developed a mouse model of airway remodeling in which OVA-sensitized mice were repeatedly exposed to intranasal OVA administration for 16 mo. Mice chronically exposed to OVA developed sustained eosinophilic airway inflammation and sustained AHR to methacholine compared with control mice. In addition, the mice chronically exposed to OVA developed features of airway remodeling, including thickening of the peribronchial smooth muscle layer, peribronchial myofibroblast accumulation, expression of the profibrotic growth factor transforming growth factor-ß, and subepithelial collagen deposition (assessed by quantitation of the area of peribronchial trichrome staining using image analysis, and immunostaining with anticollagen V antibodies). Administration of ISS systemically every other week significantly inhibited the development of AHR, eosinophilic inflammation, airway mucus production, and importantly, airway remodeling in mice chronically exposed to OVA for 36 mo. In addition, ISS significantly reduced bronchoalveolar lavage and lung levels of the profibrotic cytokine transforming growth factor-ß. These studies demonstrate that ISS prevents not only Th2-mediated airway inflammation in response to acute allergen challenge, but also airway remodeling associated with chronic allergen challenge.
Abbreviations: airway hyperresponsiveness, AHR bronchoalveolar lavage, BAL enzyme-linked immunosorbent assay, ELISA interferon, IFN interleukin, IL immunostimulatory sequences, ISS mutated oligodeoxynucleotide, M-ODN oligodeoxynucleotide, ODN ovalbumin, OVA Periodic Acid Schiff, PAS phosphate-buffered saline, PBS Respiratory Syncutial Virus, RSV transforming growth factor, TGF
This article has been cited by other articles:

|
 |

|
 |
 
H. Constabel, M. V. Stankov, C. Hartwig, T. Tschernig, and G. M. N. Behrens
Impaired Lung Dendritic Cell Migration and T Cell Stimulation Induced by Immunostimulatory Oligonucleotides Contribute to Reduced Allergic Airway Inflammation
J. Immunol.,
September 1, 2009;
183(5):
3443 - 3453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Deng, G. A. Dokshin, J. Lei, A. M. Goldsmith, K. N. Bitar, D. C. Fingar, M. B. Hershenson, and J. K. Bentley
Inhibition of Glycogen Synthase Kinase-3{beta} Is Sufficient for Airway Smooth Muscle Hypertrophy
J. Biol. Chem.,
April 11, 2008;
283(15):
10198 - 10207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Han, Y. Fan, S. Wang, L. Jiao, H. Qiu, and X. Yang
NK Cells Contribute to Intracellular Bacterial Infection-Mediated Inhibition of Allergic Responses
J. Immunol.,
April 1, 2008;
180(7):
4621 - 4628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Walters, D. W. Reid, D. P. Johns, and C. Ward
Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling
Eur. Respir. J.,
September 1, 2007;
30(3):
574 - 588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. N. Kline
Eat Dirt: CpG DNA and Immunomodulation of Asthma
Proceedings of the ATS,
July 1, 2007;
4(3):
283 - 288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Le, J. Y. Cho, M. Miller, S. McElwain, K. Golgotiu, and D. H. Broide
Inhibition of Allergen-Induced Airway Remodeling in Smad 3-Deficient Mice
J. Immunol.,
June 1, 2007;
178(11):
7310 - 7316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zhang, T. Angata, J. Y. Cho, M. Miller, D. H. Broide, and A. Varki
Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils
Blood,
May 15, 2007;
109(10):
4280 - 4287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Fixman, A. Stewart, and J. G. Martin
Basic mechanisms of development of airway structural changes in asthma
Eur. Respir. J.,
February 1, 2007;
29(2):
379 - 389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Lim, J. Y. Cho, M. Miller, K. McElwain, S. McElwain, and D. H. Broide
Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice.
Am J Physiol Lung Cell Mol Physiol,
August 1, 2006;
291(2):
L265 - L271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Miller, J. Y. Cho, K. McElwain, S. McElwain, J. Y. Shim, M. Manni, J. S. Baek, and D. H. Broide
Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice
Am J Physiol Lung Cell Mol Physiol,
January 1, 2006;
290(1):
L162 - L169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Koya, T. Kodama, K. Takeda, N. Miyahara, E.-S. Yang, C. Taube, A. Joetham, J.-W. Park, A. Dakhama, and E. W. Gelfand
Importance of Myeloid Dendritic Cells in Persistent Airway Disease after Repeated Allergen Exposure
Am. J. Respir. Crit. Care Med.,
January 1, 2006;
173(1):
42 - 55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Broide, T. Lawrence, T. Doherty, J. Y. Cho, M. Miller, K. McElwain, S. McElwain, and M. Karin
Allergen-induced peribronchial fibrosis and mucus production mediated by I{kappa}B kinase {beta}-dependent genes in airway epithelium
PNAS,
December 6, 2005;
102(49):
17723 - 17728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Hessel, M. Chu, J. O. Lizcano, B. Chang, N. Herman, S. A. Kell, M. Wills-Karp, and R. L. Coffman
Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction
J. Exp. Med.,
December 5, 2005;
202(11):
1563 - 1573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Youn, M. Miller, K. J. Baek, J. W. Han, J. Nayar, S. Y. Lee, K. McElwain, S. McElwain, E. Raz, and D. H. Broide
Immunostimulatory DNA Reverses Established Allergen-Induced Airway Remodeling
J. Immunol.,
December 15, 2004;
173(12):
7556 - 7564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Fanucchi, E. S. Schelegle, G. L. Baker, M. J. Evans, R. J. McDonald, L. J. Gershwin, E. Raz, D. M. Hyde, C. G. Plopper, and L. A. Miller
Immunostimulatory Oligonucleotides Attenuate Airways Remodeling in Allergic Monkeys
Am. J. Respir. Crit. Care Med.,
December 1, 2004;
170(11):
1153 - 1157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Kumar, C. Herbert, D. C. Webb, L. Li, and P. S. Foster
Effects of Anticytokine Therapy in a Mouse Model of Chronic Asthma
Am. J. Respir. Crit. Care Med.,
November 15, 2004;
170(10):
1043 - 1048.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society.
|
|
|